Trademark: 87299623
Word
SEPALIST
Status
Dead
Status Code
710
Status Date
Friday, January 12, 2024
Serial Number
87299623
Registration Number
5232698
Registration Date
Tuesday, June 27, 2017
Mark Type
4000
Filing Date
Thursday, January 12, 2017
Published for Opposition
Tuesday, March 14, 2017
Cancellation Date
Friday, January 12, 2024

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Events
Jan 12, 2024
Cancelled Sec. 8 (6-Yr)
Nov 8, 2022
Teas Change Of Correspondence Received
Nov 8, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 8, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 27, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jun 27, 2017
Registered-Principal Register
May 24, 2017
Extension Of Time To Oppose Process - Terminated
Apr 10, 2017
Changes/Corrections After Pub Approval Entered
Apr 3, 2017
Assigned To Petition Staff
Mar 25, 2017
Extension Of Time To Oppose Received
Mar 24, 2017
Teas Post Publication Amendment Received
Mar 14, 2017
Official Gazette Publication Confirmation E-Mailed
Mar 14, 2017
Published For Opposition
Feb 22, 2017
Notification Of Notice Of Publication E-Mailed
Jan 31, 2017
Approved For Pub - Principal Register
Jan 27, 2017
Assigned To Examiner
Jan 19, 2017
New Application Office Supplied Data Entered
Jan 16, 2017
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24